Significant Ownership of MPM BioImpact LLC

Signature - Title
Christopher Wolf - Chief Financial Officer
Location
Boston, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by MPM BioImpact LLC.

Follow Filing Activity

Follow MPM BioImpact LLC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Significant Ownership of MPM BioImpact LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 12% $15,698,705 -$5,918,942 10,679,391 -27% MPM BioImpact LLC 31 Dec 2025
DBVT DBV TECHNOLOGIES S.A. Ordinary Shares, nominal value 0.01 euro per share 9.9% $440,706,975 24,579,307 MPM BioImpact LLC 31 Dec 2025
CLYM Climb Bio, Inc. Common Stock, par value $0.0001 per share 5.6% $13,437,544 2,671,480 MPM BioImpact LLC 31 Dec 2025
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.001 per share 4.1% $15,180,764 -$7,952,556 5,622,505 -34% MPM BioImpact LLC 30 Jun 2025

Schedules 13D/G Reported by MPM BioImpact LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .